Abstract

BackgroundThe Australian Synchrotron Imaging and Medical Beamline (IMBL) was designed as the world’s widest synchrotron X-ray beam, enabling both clinical imaging and therapeutic applications for humans as well as the imaging of large animal models. Our group is developing methods for imaging the airways of newly developed CF animal models that display human-like lung disease, such as the CF pig, and we expect that the IMBL can be utilised to image airways in animals of this size.MethodsThis study utilised samples of excised tracheal tissue to assess the feasibility, logistics and protocols required for airway imaging in large animal models such as pigs and sheep at the IMBL. We designed an image processing algorithm to automatically track and quantify the tracheal mucociliary transport (MCT) behaviour of 103 μm diameter high refractive index (HRI) glass bead marker particles deposited onto the surface of freshly-excised normal sheep and pig tracheae, and assessed the effects of airway rehydrating aerosols.ResultsWe successfully accessed and used scavenged tracheal tissue, identified the minimum bead size that is visible using our chosen imaging setup, verified that MCT could be visualised, and that our automated tracking algorithm could quantify particle motion. The imaging sequences show particles propelled by cilia, against gravity, up the airway surface, within a well-defined range of clearance speeds and with examples of ‘clumping’ behaviour that is consistent with the in vivo capture and mucus-driven transport of particles.ConclusionThis study demonstrated that the wide beam at the IMBL is suitable for imaging MCT in ex vivo tissue samples. We are now transitioning to in vivo imaging of MCT in live pigs, utilising higher X-ray energies and shorter exposures to minimise motion blur.

Highlights

  • The Australian Synchrotron Imaging and Medical Beamline (IMBL) was designed as the world’s widest synchrotron X-ray beam, enabling both clinical imaging and therapeutic applications for humans as well as the imaging of large animal models

  • To rapidly determine the efficacy of genetic and pharmaceutical therapies for Cystic fibrosis (CF) we have developed mucociliary transport (MCT) monitoring methods in live anaesthetised normal and CFTR-null mice to measure the transport rate and behaviour of individual deposited 10-30 μm diameter high refractive index (HRI) glass bead marker particles using propagation-based synchrotron phase contrast X-ray imaging (PCXI) [4]

  • Fluoroscopy and CT imaging systems are not able to resolve particles of this size. These synchrotron X-ray MCT imaging methods have been developed in mice over more than 8 years at the SPring-8 synchrotron in Japan, and we have recently begun to transition them to the Imaging and Medical Beamline (IMBL) at the Australian Synchrotron [5]

Read more

Summary

Introduction

The Australian Synchrotron Imaging and Medical Beamline (IMBL) was designed as the world’s widest synchrotron X-ray beam, enabling both clinical imaging and therapeutic applications for humans as well as the imaging of large animal models. To rapidly determine the efficacy of genetic and pharmaceutical therapies for CF we have developed MCT monitoring methods in live anaesthetised normal and CFTR-null mice to measure the transport rate and behaviour of individual deposited 10-30 μm diameter high refractive index (HRI) glass bead marker particles using propagation-based synchrotron phase contrast X-ray imaging (PCXI) [4]. Fluoroscopy and CT imaging systems are not able to resolve particles of this size These synchrotron X-ray MCT imaging methods have been developed in mice over more than 8 years at the SPring-8 synchrotron in Japan, and we have recently begun to transition them to the Imaging and Medical Beamline (IMBL) at the Australian Synchrotron [5]

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.